CLHO Stock Overview
Cleopatra Hospital Group S.A.E. operates hospitals in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CLHO from our risk checks.
My Notes
NewNotes are coming soon
Cleopatra Hospital Group S.A.E. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م5.50 |
| 52 Week High | ج.م5.65 |
| 52 Week Low | ج.م3.81 |
| Beta | 0.41 |
| 1 Month Change | 3.38% |
| 3 Month Change | 41.39% |
| 1 Year Change | 12.94% |
| 3 Year Change | -5.01% |
| 5 Year Change | 25.57% |
| Change since IPO | -43.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLHO | EG Healthcare | EG Market | |
|---|---|---|---|
| 7D | 4.8% | 1.7% | 2.8% |
| 1Y | 12.9% | -3.1% | 33.2% |
Return vs Industry: CLHO exceeded the EG Healthcare industry which returned -3.1% over the past year.
Return vs Market: CLHO underperformed the EG Market which returned 33.2% over the past year.
Price Volatility
| CLHO volatility | |
|---|---|
| CLHO Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in EG Market | 8.8% |
| 10% least volatile stocks in EG Market | 4.2% |
Stable Share Price: CLHO is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CLHO's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | Ahmed Ezzeldin Abdelaal | https://www.cleopatrahospitals.com |
Cleopatra Hospital Group S.A.E. operates hospitals in Egypt. The company’s hospitals provide an array of general and emergency healthcare services in the areas of cardiology, radiology, orthopedic, urology, and others. It also offers various medical services, such as surgeries, admission, medical supervision, laboratory, tests, and outpatient clinic services; and telemedicine services, including digital consultation and follow up appointments.
Cleopatra Hospital Group S.A.E. Fundamentals Summary
| CLHO fundamental statistics | |
|---|---|
| Market Cap | ج.م8.10b |
| Earnings (TTM) | ج.م293.66m |
| Revenue (TTM) | ج.م2.51b |
27.6x
P/E Ratio3.2x
P/S RatioIs CLHO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLHO income statement (TTM) | |
|---|---|
| Revenue | ج.م2.51b |
| Cost of Revenue | ج.م1.65b |
| Gross Profit | ج.م864.07m |
| Other Expenses | ج.م570.41m |
| Earnings | ج.م293.66m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.20 |
| Gross Margin | 34.37% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 8.1% |
How did CLHO perform over the long term?
See historical performance and comparison